| Previous Close | 3.17 |
| Open | 3.23 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 3.19 - 3.25 |
| 52 Week Range | 0.36 - 6.48 |
| Volume | 266,938 |
| Avg. Volume | 189,517 |
| Market Cap | 137.55M |
| Beta | 0.62 |
| PE Ratio (TTM) | -1.70 |
| EPS (TTM) | -1.88 |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.50 |
- PR Newswire•21 days ago
CTI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference
SEATTLE , Aug. 31, 2017 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that management will present at the 24th Annual BioCentury NewsMakers in the Biotech Industry ...
- Thomson Reuters StreetEvents•last month
Edited Transcript of CTIC earnings conference call or presentation 3-Aug-17 8:30pm GMT
Q2 2017 CTi Biopharma Corp Earnings Call
- Associated Press•2 months ago
CTI BioPharma posts 2Q profit
The Seattle-based company said it had profit of 3 cents per share. Earnings, adjusted for stock option expense, came to 6 cents per share. The biotechnology company posted revenue of $22.2 million in the ...
